Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 14901-14950 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04153643
Meniscus Surgery Registry
N/AActive, not recruiting
1,000 participants
Started: Nov 15, 2019 · Completed: Nov 15, 2040
1 condition1 sponsor1 location
NCT03924414
Trial of Parkinson's And Zoledronic Acid
PHASE4Active, not recruiting
2,650 participants
Started: Nov 15, 2019 · Completed: Oct 31, 2025
9 conditions6 sponsors77 locations
NCT04120480
Effectiveness of PGx Testing
NAActive, not recruiting
600 participants
Started: Nov 15, 2019 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT03817970
Cisplatin Disposition and Kidney Injury
PHASE3Active, not recruiting
72 participants
Started: Nov 15, 2019 · Completed: Dec 31, 2027
1 condition4 sponsors2 locations
NCT03390686
A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients
PHASE3Active, not recruiting
650 participants
Started: Nov 15, 2019 · Completed: Dec 31, 2025
2 conditions1 sponsor18 locations
NCT04182633
MTT for Children With ASD Who Have Gastrointestinal Disorders
PHASE2Active, not recruiting
50 participants
Started: Nov 15, 2019 · Completed: Dec 30, 2025
4 conditions2 sponsors1 location
NCT03784755
Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer
NAActive, not recruiting
409 participants
Started: Nov 15, 2019 · Completed: Jul 30, 2027
1 condition2 sponsors18 locations
NCT03981445
Integrated HIV Prevention and HCV Care for PWID
NAActive, not recruiting
446 participants
Started: Nov 14, 2019 · Completed: Dec 31, 2025
4 conditions8 sponsors3 locations
NCT04198194
Apple Heart & Movement Study
N/AActive, not recruiting
500,000 participants
Started: Nov 14, 2019 · Completed: Feb 28, 2025
1 condition2 sponsors1 location
NCT04232241
Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia
PHASE2Active, not recruiting
167 participants
Started: Nov 14, 2019 · Completed: Nov 26, 2026
3 conditions3 sponsors24 locations
NCT04047251
A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma
PHASE1Active, not recruiting
96 participants
Started: Nov 14, 2019 · Completed: Jul 31, 2026
2 conditions1 sponsor7 locations
NCT04276363
Families, Children and Teachers Thriving Together
NAActive, not recruiting
491 participants
Started: Nov 14, 2019 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT04148391
NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)
PHASE2Active, not recruiting
99 participants
Started: Nov 14, 2019 · Completed: Dec 30, 2022
4 conditions3 sponsors26 locations
NCT04082429
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
PHASE3Active, not recruiting
156 participants
Started: Nov 13, 2019 · Completed: Feb 21, 2028
2 conditions1 sponsor81 locations
NCT04070443
Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
PHASE2Active, not recruiting
170 participants
Started: Nov 13, 2019 · Completed: Jun 1, 2029
2 conditions1 sponsor28 locations
NCT04002362
Symptom Clusters in Children With Exacerbation-prone Asthma
PHASE2Active, not recruiting
65 participants
Started: Nov 13, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT04147884
A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation
NAActive, not recruiting
4 participants
Started: Nov 13, 2019 · Completed: Nov 30, 2026
3 conditions1 sponsor4 locations
NCT04055909
Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
PHASE2Active, not recruiting
355 participants
Started: Nov 13, 2019 · Completed: May 9, 2023
1 condition1 sponsor43 locations
NCT03888105
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
PHASE2Active, not recruiting
515 participants
Started: Nov 13, 2019 · Completed: Dec 15, 2028
1 condition1 sponsor119 locations
NCT04738071
International Multicenter Patent foRamen OVale & strokE (IMPROVE) Registry
N/AActive, not recruiting
3,730 participants
Started: Nov 13, 2019 · Completed: Nov 13, 2025
4 conditions1 sponsor1 location
NCT03997630
Management of Moderately Hypoxemic Thoracic Trauma
NAActive, not recruiting
770 participants
Started: Nov 12, 2019 · Completed: Feb 28, 2026
2 conditions1 sponsor18 locations
NCT04097002
First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Nov 12, 2019 · Completed: Dec 31, 2024
1 condition2 sponsors5 locations
NCT03964792
Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains CD34+ Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene in Patients With Sickle Cell Disease (DREPAGLOBE)
PHASE1/PHASE2Active, not recruiting
6 participants
Started: Nov 12, 2019 · Completed: Jan 31, 2024
1 condition1 sponsor1 location
NCT04405557
The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common Malignant Tumor
N/AActive, not recruiting
757 participants
Started: Nov 12, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors8 locations
NCT04162015
A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma
PHASE1Active, not recruiting
22 participants
Started: Nov 12, 2019 · Completed: Nov 30, 2026
1 condition2 sponsors7 locations
NCT04045301
Omalizumab to Accelerate a Symptom-driven Multi-food OIT
PHASE2Active, not recruiting
90 participants
Started: Nov 11, 2019 · Completed: Mar 31, 2026
4 conditions4 sponsors3 locations
NCT04140500
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
PHASE1/PHASE2Active, not recruiting
170 participants
Started: Nov 11, 2019 · Completed: Jun 30, 2026
4 conditions1 sponsor25 locations
NCT03841097
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
PHASE4Active, not recruiting
60 participants
Started: Nov 11, 2019 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT03629743
Correlate of Surface Electroencephalogram (EEG) With Implanted EEG Recordings (ECOG)
N/AActive, not recruiting
20 participants
Started: Nov 11, 2019 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT04157205
Prospective Evaluation Of Exercise-Induced Cardiac Conduction Instability In Predicting Ventricular Fibrillation Events In Hypertrophic Cardiomyopathy
NAActive, not recruiting
200 participants
Started: Nov 10, 2019 · Completed: Dec 1, 2026
1 condition11 sponsors1 location
NCT04173208
Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study
NAActive, not recruiting
90 participants
Started: Nov 10, 2019 · Completed: Jan 31, 2025
3 conditions2 sponsors1 location
NCT04041050
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
PHASE1Active, not recruiting
85 participants
Started: Nov 8, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor42 locations
NCT03817398
Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia
PHASE2Active, not recruiting
110 participants
Started: Nov 8, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors173 locations
NCT05101239
Acute and Mild TBI Injury in Military and Civilian Population Using Advanced MR Imaging
N/AActive, not recruiting
160 participants
Started: Nov 8, 2019 · Completed: Jun 30, 2026
1 condition3 sponsors2 locations
NCT03816332
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
PHASE1Active, not recruiting
12 participants
Started: Nov 8, 2019 · Completed: Sep 19, 2026
21 conditions1 sponsor7 locations
NCT04943380
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
N/AActive, not recruiting
684 participants
Started: Nov 8, 2019 · Completed: Dec 31, 2025
2 conditions1 sponsor10 locations
NCT03900637
PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate
PHASE2Active, not recruiting
122 participants
Started: Nov 8, 2019 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06623435
Real World and Genomic Data Based Asthma Insight Through Network Analysis
N/AActive, not recruiting
1,073 participants
Started: Nov 7, 2019 · Completed: Dec 31, 2025
1 condition4 sponsors5 locations
NCT03978442
CPT-SMART for Treatment of PTSD and Cigarette Smoking
PHASE4Active, not recruiting
120 participants
Started: Nov 7, 2019 · Completed: Oct 10, 2025
2 conditions1 sponsor1 location
NCT04046575
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
PHASE1Active, not recruiting
12 participants
Started: Nov 7, 2019 · Completed: Nov 20, 2029
3 conditions1 sponsor1 location
NCT04154917
Effectiveness of a Comprehensive Patient-centered Hospital Discharge Planning Intervention for Frail Older Adults
NAActive, not recruiting
72 participants
Started: Nov 7, 2019 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04067570
Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer
NAActive, not recruiting
30 participants
Started: Nov 7, 2019 · Completed: Oct 31, 2030
2 conditions1 sponsor1 location
NCT03875573
Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:
PHASE2Active, not recruiting
147 participants
Started: Nov 6, 2019 · Completed: Sep 30, 2029
1 condition3 sponsors7 locations
NCT04030325
Motivating Campus Change Study
NAActive, not recruiting
1,012 participants
Started: Nov 6, 2019 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT04091984
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)
N/AActive, not recruiting
5,000 participants
Started: Nov 6, 2019 · Completed: Oct 1, 2027
1 condition2 sponsors55 locations
NCT04093869
Improving Lung Transplant Outcomes With Coping Skills and Physical Activity
NAActive, not recruiting
180 participants
Started: Nov 6, 2019 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT04086264
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia
PHASE1/PHASE2Active, not recruiting
218 participants
Started: Nov 6, 2019 · Completed: Feb 28, 2027
1 condition1 sponsor29 locations
NCT04104672
A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
PHASE1Active, not recruiting
196 participants
Started: Nov 6, 2019 · Completed: May 31, 2027
1 condition1 sponsor16 locations
NCT04112290
A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy
N/AActive, not recruiting
260 participants
Started: Nov 5, 2019 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT04025879
A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer
PHASE3Active, not recruiting
461 participants
Started: Nov 5, 2019 · Completed: Jul 30, 2027
1 condition1 sponsor108 locations